Back
Neurogene Stock Predictions
Sponsored
NGNE
Sponsored
This Cash Calendar Could Help Ease the Bite of Inflation
Sign up here to claim yours.
Sell
20
NGNE
Neurogene
Last Price:
25.58
Seasonality Move:
25.48%
7 Day Trial
ALL ACCESS PASS
$
7
The $6 Billion Income Secret of the World's Most Successful Investor
Discover the 3-step trick to finding top dividend stocks to buy and hold foreverNeurogene Stock Forecast
- Over the next 52 weeks, Neurogene has on average historically risen by 21.5% based on the past 10 years of stock performance.
- Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Neurogene Stock Undervalued?
The current Neurogene [NGNE] share price is $25.43. The Score for NGNE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Neurogene Stock Go Up Next Year?
- Over the next 52 weeks, Neurogene has on average historically risen by 21.5% based on the past 10 years of stock performance.
Neurogene Stock Rating
Sell
20
Neurogene (NGNE)
is a Sell
Is Neurogene overpriced?
- Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Neurogene Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
74.49
52-Week Low:
12.49
Prediction Charts
Market Cap:
377.76M
Price in USD:
25.43
Volume:
317.56K
Beta:
-1.26
Technical Analysis
SMA50:
43.45
SMA100:
41.03
SMA200:
38.56
52-Wk Change:
86.44%
Stock Predictions
-
Is Neurogene stock public?
Yes, Neurogene is a publicly traded company. -
What is the Neurogene stock quote today?
The Neurogene stock price is 25.43 USD today. -
How to buy Neurogene stock online?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-11 | 70.04 | 71.53 | 74.49 | 69.49 |
Nov-12 | 48.28 | 40.00 | 49.37 | 35.60 |
Nov-13 | 39.67 | 39.54 | 41.33 | 39.08 |
Nov-14 | 39.50 | 39.20 | 43.24 | 38.97 |
Nov-15 | 38.84 | 34.52 | 39.20 | 34.52 |
Nov-18 | 22.24 | 19.82 | 23.79 | 18.94 |
Nov-19 | 20.90 | 17.23 | 20.99 | 17.01 |
Nov-20 | 17.31 | 15.33 | 17.45 | 15.28 |
Nov-21 | 15.06 | 15.59 | 16.15 | 14.44 |
Nov-22 | 15.48 | 20.30 | 20.93 | 15.48 |
Nov-25 | 21.05 | 22.32 | 22.57 | 20.50 |
Nov-26 | 25.97 | 26.87 | 27.61 | 24.23 |
Nov-27 | 27.14 | 25.80 | 27.68 | 24.60 |
Nov-29 | 26.71 | 25.43 | 26.75 | 24.78 |
Neurogene Earnings
Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene Forecast Revenue Growth
Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.